AllDocs -> cancers

FORM 143913 (January 2005) MD, MH, PR, CW Colon Cancer Screening Why screen for colon cancer ? The colon , or large intestine, is the last portion of the gastrointestinal tract and ends with the rectum. Cancer of the colon is the second most frequent cause of death from cancer in the United States, resulting in about 57,000 deaths per year. The risk of colon cancer increases as people age – 90 percent of colon cancers occur in individuals over 50 years of age. Colon cancer is also more common in people with a family history of colon cancer , or a personal history of colon polyps or inflammatory bowel disease. Cigarette smoking and excessive alcohol consumption may also increase the risk of colon cancer . The good news is that early screening can lead to both prevention of and better cure rates for colon cancer . How can screening prevent colon cancer ? ...

FDA Background for Colon Cancer Endpoints Workshop This document provides FDA background information for a November, 2003 public workshop to discuss endpoints for the approval of colon cancer drugs. I. FDA examination of endpoints for cancer drug approval The Food and Drug Administration is soliciting input on what endpoints are acceptable as the basis for cancer drug approval. Endpoints will be examined for the most common cancers, such as lung cancer , colon cancer , etc. For each cancer , FDA will hold public workshops to identify important issues, and these issues will be discussed in meetings of the Oncologic Drugs Advisory Committee (ODAC). Subsequently, guidance documents will be published describing FDA's current thinking on endpoints for cancer drug approval. Workshop planning is guided by a steering committee that includes representation from the FDA, the National Cancer Institute, ...

A Novel Biomarker for Diagnosis of Ulcerative Colitis and Colon Cancer Background Tropomyosins are microfilament-associated proteins found in all eukaryotes and have been implicated in autoimmune diseases such as ulcerative colitis. To date, eight different isoforms (hTM1, hTM2, hTM3, hTMsma, hTM5a, hTM5b, hTM4, and hTM5) have been identified. Although anti- tropomyosin autoantibodies have been detected in the sera of patients with ulcerative colitis, the autoantigen triggering the autoantibody response has not been definitively identified. Previous studies at UMDNJ have identified hTM5 as the predominant immunogen in ulcerative colitis patients. Ulcerative colitis is difficult to diagnose because its symptoms are similar to other intestinal disorders. Furthermore, about 5% of patients with ulcerative colitis develop colon cancer . Thus, the identification of the autoantigen(s), in particular, the specific ...

Technology Evaluation Center BlueCross BlueShield Association ® ® An Association of Independent Blue Cross and Blue Shield Plans ©2004 Blue Cross and Blue Shield Association. Reproduction without prior authorization is prohibited. 1 NOTICE OF PURPOSE: TEC Assessments are scientific opinions, provided solely for informational purposes. TEC Assessments should not be construed to suggest that the Blue Cross Blue Shield Association, Kaiser Permanente Medical Care Program or the TEC Program recommends, advocates, requires, encourages, or discourages any particular treatment, procedure, or service; any particular course of treatment, procedure, or service; or the payment or non-payment of the technology or technologies evaluated. Assessment Program Volume 19, No. 6 July 2004 Executive Summary Computed tomographic (CT) colonography, ...

Project on Medical Imaging. Supervisors: Dr. Abd-krim Seghouane, Systems Engineering and complex Systems Program National ICT Australia. Dr. Kevin Osborn, Canberra Medical Imaging Group. Pre-processing data for colon cancer early detection Colorectal Carcinoma or colon cancer is an important cause of deaths in the world: 56 000 deaths reported in the USA in 1998. Nevertheless, the early detection of adenomatous polyps, which are the precursors of colon cancer , can prevent the occurrence of colorectal cancer . Indeed, the removal of smaller sized polyps can eliminate over 90% of colon cancer case. Unfortunately, no simple, rapid and effective method for colorectal cancer screening currently exists. So far, the techniques, which have been developed, are either invasive or lack robustness. Indeed, the Fiberoptic Colonoscopy is invasive and the Computed Tomography Colonography ...

Technology Evaluation Center BlueCross BlueShield Association ® ® An Association of Independent Blue Cross and Blue Shield Plans ©2006 Blue Cross and Blue Shield Association. Reproduction without prior authorization is prohibited. 1 NOTICE OF PURPOSE: TEC Assessments are scientific opinions, provided solely for informational purposes. TEC Assessments should not be construed to suggest that the Blue Cross Blue Shield Association, Kaiser Permanente Medical Care Program or the TEC Program recommends, advocates, requires, encourages, or discourages any particular treatment, procedure, or service; any particular course of treatment, procedure, or service; or the payment or non-payment of the technology or technologies evaluated. Assessment Program Volume 21, No. 6 August 2006 Executive Summary Background Various methods for ...

1 Fecal Occult Blood Tests The fecal occult blood test (FOBT) is the least expensive and easiest colon cancer screening test recommended by national guidelines. 1-5 Large randomized clinical trials have also shown that FOBT reduces mortality from colon cancer . 6 However, the effectiveness of FOBTs is partially determined by how providers conduct the tests. Providers must select the brand of FOBT to use, including whether to use a guaiac-based test or an immunochemical test. Providers should conduct the FOBT through an at-home multiple specimen test rather than a single sample in-clinic test. In addition, when a patient has a positive FOBT, providers must order the appropriate follow-up test. While FOBTs are shown to reduce colorectal cancer incidence and mortality, the effectiveness of FOBTs depend on the choices providers make. 7-12 FOBT Types ...

Nebraska Health and Human Services Nebraska Colon Cancer Screening Program 301 Centennial Mall South - P.O. Box 94817 Lincoln, NE 68509-4817 Toll Free: 1-800-532-2227 Fax: 471-0913 E-mail: ncp@hhss.ne.gov Website: www.hhss.ne.gov/crc CLIENT INFORMATION BOOKLET In this booklet you will find information on how Nebraska Colon Cancer Screening Program can serve you. Fecal Occult Blood T est Kit Colonoscopy Colon Health Screening Exams Version June 2006 Nebraska Colon Cancer Screening Program Page 2 What is the Nebraska Colon Cancer Screening Program (NCP)? NCP is the newest program added to Every Woman Matters (EWM). Nebraska is one of only five such programs in the nation. The goal of NCP is to increase screening for colon ...

P.O.Box 2345, Beijing 100023,China World J Gastroenterol 2003;9(9):1976-1980 Fax: +86-10-85381893 World Journal of Gastroenterology E-mail: wjg@wjgnet.com www.wjgnet.com Copyright © 2003 by The WJG Press ISSN 1007-9327 • COLORECTAL CANCER • EffectsofDNAmethylationonexpressionoftumorsuppressorgenes and proto-oncogene in human colon cancer cell lines Jing-Yuan Fang, Juan Lu, Ying-Xuan Chen, Li Yang Jing-Yuan Fang, Juan Lu, Ying-Xuan Chen, Li Yang, Shanghai Institute of Digestive Diseases, Renji Hospital, Shanghai Second Medical University, Shanghai 200001, China Supported by the National Natural Science Foundation of China, No.30170413, and Ph.D Funds from the Ministry of Education of China, No.199946, and the Key Subject Funds of Shanghai Education Committee to Jing-Yuan Fang Correspondence to: Dr. Jing-Yuan Fang, Shanghai Institute of ...

Cancer : Cancer is a common disease and is identified in 1 out of 3 Canadians in their lifetime. It begins as a change in a single cell and this cell multiplies and creates a small group of abnormal cells within a specific tissue. This uncontrolled growth can lead to the development of a tumour. The development of cancer is due to both genetic and non- genetic factors. Colon cancer is one of the more frequently seen types of cancers and is diagnosed in approximately 16,000 people in Canada every year. Most individuals who have colon cancer have not inherited a gene that has predisposed them to cancer . Their cancer is thought to occur by chance and the cause is unknown. It is estimated that only 5-10% of colon cancers are hereditary and said to “run in families”. Colorectal Cancer Cancer Genetics: Genes ...

Colon Cancer Screening “Health Spotlight” Launched on Free Health Portal Health Site Guide http://www.healthsiteguide.com , the leading portal for pre-searched, direct links to health information, debuts new feature with a focus on colon cancer prevention Great Neck, N.Y. (PRWEB) July 5, 2006 -- Colon cancer is one of the leading causes of death in the U.S., and also one of the most preventable forms of cancer . Early stage detection of colorectal tumors means a 90 percent survival rate, and is widely recommended for people over 50, or people over 40 with a family history of the disease. Because the condition often shows no symptoms in its early stages, the importance of screening for colon cancer cannot be understated. For many, however, thoughts of colonoscopies and rectal procedures can understandably be a source of anxiety. Current healthcare statistics indicate low screening rates for those most ...

cancer Genetic Testing for Hereditary Breast and Ovarian Cancer : Potential Ethical Issues Jennifer E. Axilbund, M.S., C.G.C. Cancer Risk Assessment Program The Johns Hopkins Hospital June 15, 2005 What Percentage of Cancer is Considered to be Hereditary? 60-85% of cancer is thought to be sporadic 10-30% of cancer is thought to be familial 5-10% of cancer is thought to be hereditary Most Cancer Susceptibility Genes Are Dominant With Incomplete Penetrance ASCO Penetrance is often incomplete May appear to “skip” generations Individuals inherit altered cancer susceptibility gene, not cancer Normal Carrier, affected with cancer Susceptible Carrier ...